| scholarly article | Q13442814 |
| P50 | author | Pier Alberto Bertazzi | Q30004136 |
| Angela C Pesatori | Q56452885 | ||
| Tommaso Cavalleri | Q86836454 | ||
| Valentina Bollati | Q40951527 | ||
| Silvia Fustinoni | Q41647112 | ||
| Laura Angelici | Q56383913 | ||
| P2093 | author name string | S Iodice | |
| L Vigna | |||
| V Motta | |||
| C Favero | |||
| L Dioni | |||
| B Albetti | |||
| S Sucato | |||
| P2860 | cites work | Real-time PCR in virology | Q24514920 |
| Translating the A1C assay into estimated average glucose values | Q24655833 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Insulin resistance and skeletal muscle vasculature: significance, assessment and therapeutic modulators | Q28081458 | ||
| Chromium as a supplement | Q28142234 | ||
| Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc | Q28206868 | ||
| The trail of chromium(III) in vivo from the blood to the urine: the roles of transferrin and chromodulin | Q28208654 | ||
| Susceptibility to particle health effects, miRNA and exosomes: rationale and study protocol of the SPHERE study | Q28382944 | ||
| Incorporating epigenetic data into the risk assessment process for the toxic metals arsenic, cadmium, chromium, lead, and mercury: strategies and challenges | Q28390395 | ||
| MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3 | Q28564217 | ||
| Systemic approach to identify serum microRNAs as potential biomarkers for acute myocardial infarction | Q33677280 | ||
| Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486 | Q33732748 | ||
| Continuous glucose monitoring system and new era of early diagnosis of diabetes in high risk groups. | Q33750414 | ||
| Haemolysis during sample preparation alters microRNA content of plasma. | Q34016595 | ||
| [Environmental and biological limit values and reference values] | Q57112972 | ||
| Plasma chromium and chromium excretion in diabetes | Q70049251 | ||
| Chromium deficiency after long-term total parenteral nutrition | Q70289008 | ||
| Effect of trivalent chromium on glucose tolerance | Q72839089 | ||
| Zinc, copper, iron, and chromium concentrations in young patients with type 2 diabetes mellitus | Q83478041 | ||
| Influence of the confounding factors age and sex on microRNA profiles from peripheral blood | Q88202208 | ||
| Chromium intake, absorption and excretion of subjects consuming self-selected diets | Q93564630 | ||
| MicroRNA microarray expression profiling in human myocardial infarction | Q34092891 | ||
| Metabolic complications of obesity | Q34143830 | ||
| MicroRNA-301a mediated regulation of Kv4.2 in diabetes: identification of key modulators | Q34662020 | ||
| Circulating microRNA expression profile and systemic right ventricular function in adults after atrial switch operation for complete transposition of the great arteries. | Q34990770 | ||
| Elemental speciation by chromatographic separation with inductively coupled plasma mass spectrometry detection | Q35012739 | ||
| Signature of circulating microRNAs as potential biomarkers in vulnerable coronary artery disease | Q35067334 | ||
| Increased insulin resistance is associated with increased urinary excretion of chromium in non-diabetic, normotensive Saudi adults. | Q35522315 | ||
| Obesity as a cardiovascular risk factor | Q35609183 | ||
| MicroRNA-21 in cardiovascular disease | Q36727758 | ||
| A computational screen for mouse signaling pathways targeted by microRNA clusters. | Q36740718 | ||
| Chromium in metabolic and cardiovascular disease | Q36977887 | ||
| MicroRNAs--micro in size but macro in function | Q37255242 | ||
| Inducible gene expression: diverse regulatory mechanisms | Q37737546 | ||
| Diabesity: therapeutic options | Q37762294 | ||
| PI3 kinase regulation of skeletal muscle hypertrophy and atrophy | Q37769163 | ||
| MicroRNAs in the onset and development of cardiovascular disease | Q38150359 | ||
| Insulin resistance associated genes and miRNAs | Q38225286 | ||
| Micro RNA: an epigenetic regulator of type 2 diabetes. | Q38269991 | ||
| MicroRNA regulatory networks in human adipose tissue and obesity. | Q38366874 | ||
| MiR-106b and MiR-15b modulate apoptosis and angiogenesis in myocardial infarction | Q38497005 | ||
| MiR-301a mediates the effect of IL-6 on the AKT/GSK pathway and hepatic glycogenesis by regulating PTEN expression | Q38897459 | ||
| Dietary chromium intake. Freely chosen diets, institutional diet, and individual foods | Q42126618 | ||
| Evaluation of toxic elements in scalp hair samples of myocardial infarction patients at different stages as related to controls. | Q43418985 | ||
| Tissue and subcellular distribution of chromium picolinate with time after entering the bloodstream | Q44350026 | ||
| Clusters of AMI risk factors and their association with left ventricular hypertrophy: a population-based study within the Skaraborg Project, Sweden. | Q45907552 | ||
| Chromium status and glucose tolerance in Saudi men with and without coronary artery disease. | Q46065961 | ||
| Chromium and insulin resistance | Q46195517 | ||
| Low toenail chromium concentration and increased risk of nonfatal myocardial infarction | Q46562114 | ||
| High-resolution ICP-MS determination of Ti, V, Cr, Co, Ni, and Mo in human blood and urine of patients implanted with a hip or knee prosthesis. | Q47657311 | ||
| The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group | Q47690865 | ||
| Interaction of chromium with insulin: a progress report | Q47873513 | ||
| Plasma mass spectrometry as a detector for chemical speciation studies | Q49248097 | ||
| Serum and urine chromium concentrations in elderly diabetics. | Q51566392 | ||
| MicroRNA-21, induced by high glucose, modulates macrophage apoptosis via programmed cell death 4. | Q53589672 | ||
| MicroRNA-451 regulates p38 MAPK signaling by targeting of Ywhaz and suppresses the mesangial hypertrophy in early diabetic nephropathy. | Q54568873 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International | Q42553662 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | obesity | Q12174 |
| microRNA expression | Q60681249 | ||
| P304 | page(s) | 142-148 | |
| P577 | publication date | 2016-10-12 | |
| P1433 | published in | European Journal of Clinical Nutrition | Q15756702 |
| P1476 | title | Urinary chromium is associated with changes in leukocyte miRNA expression in obese subjects | |
| P478 | volume | 71 |
Search more.